Jeannette de la Torre
Nurse Practitioner · Miami, FLNPI 1285995654
Payments from drug & device makers
Across 350 payments — averaging $19.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Lilly USA, LLC$959
- Novo Nordisk$803
- Sanofi-aventis U.S. LLC$428
- Bayer$399
- Biohaven Pharmaceutical Holding Company Ltd.$326
- plus $2K from 26 others
What the payments were for
- Food & beverage$6,649100%
- Education$130%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 81 | $1,321 |
| Lilly USA, LLC | 55 | $959 |
| Novo Nordisk | 39 | $803 |
| Sanofi-aventis U.S. LLC | 21 | $428 |
| Bayer | 15 | $399 |
| Biohaven Pharmaceutical Holding Company Ltd. | 15 | $326 |
| AstraZeneca | 17 | $319 |
| Amgen | 14 | $303 |
| Biohaven Pharmaceuticals, Inc. | 15 | $299 |
| Boehringer Ingelheim | 14 | $278 |
| Pfizer | 13 | $243 |
| GSK | 9 | $184 |
| Lundbeck LLC | 5 | $110 |
| Merck | 5 | $101 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $61 |
| Dexcom, Inc. | 3 | $57 |
| Idorsia Pharmaceuticals US Inc | 3 | $49 |
| Biogen | 3 | $44 |
| Halozyme Inc | 2 | $44 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $43 |
| Ironwood Pharmaceuticals, Inc | 2 | $39 |
| Arbor Pharmaceuticals, Inc. | 2 | $37 |
| Eisai Inc. | 2 | $36 |
| Nabriva Therapeutics, PLC | 2 | $29 |
| Radius Health, Inc. | 1 | $26 |
| Alvogen Inc | 1 | $23 |
| Exact Sciences | 1 | $21 |
| Nestle Healthcare Nutrition Inc. | 1 | $20 |
| Shield Therapeutics Inc | 1 | $19 |
| Abbott | 1 | $16 |
| Kowa Pharmaceuticals America, Inc. | 1 | $14 |
| Mission Pharmacal Company | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Repatha$122
- MOUNJARO$117
- NURTEC ODT$113
How this compares
$6,662 in reported general payments places this provider in the 95th percentile of 8,290 nurse practitioner providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 62 | $66,774 |
| OzempicSemaglutide | 45 | $45,069 |
| TradjentaLinagliptin | 37 | $39,579 |
| MyrbetriqMirabegron | 35 | $30,817 |
| JardianceEmpagliflozin | 24 | $30,713 |
| TrulicityDulaglutide | 31 | $30,014 |
| Janumet XrSitagliptin Phos/Metformin Hcl | 19 | $27,950 |
| ProliaDenosumab | 15 | $26,323 |
| Synjardy XrEmpagliflozin/Metformin Hcl | 21 | $24,594 |
| LinzessLinaclotide | 16 | $20,283 |
| JanuviaSitagliptin Phosphate | 17 | $16,231 |
| JentaduetoLinagliptin/Metformin Hcl | 19 | $13,641 |
| LivaloPitavastatin Calcium | 12 | $11,743 |
| Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog | 11 | $8,255 |
| BelsomraSuvorexant | 15 | $6,704 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimTradjenta, Jardiance, Synjardy Xr, Jentadueto | $278 | $108,526101 claims |
| Lilly USA, LLCMounjaro, Trulicity | $959 | $96,78793 claims |
| MerckJanumet Xr, Januvia, Belsomra | $101 | $50,88551 claims |
| Novo NordiskOzempic | $803 | $45,06945 claims |
| AmgenProlia | $303 | $26,32315 claims |
| AbbVieLinzess, Synthroid | $1,321 | $25,47563 claims |
| Kowa Pharmaceuticals America, Inc.Livalo | $14 | $11,74312 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 8,290 nurse practitioner providers in Florida.
Other nurse practitioner in Miami
- Margarita FernandezMiami$311K
- Maya BloombergMiami$202K
- Haydee KapinMiami$97K
- Terri PollackMiami$59K
- Amber FederizoMiami$39K
- Patricia Novoa-VogtMiami$35K
- Moriane JosephMiami$23K
- Jolanta BaginskiClearwater$494K
- Adissa PerezWinter Park$370K
- April WessonTampa$342K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.